CME
CME
CME Group Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $1.65B ▲ | $388M ▲ | $1.17B ▲ | 70.84% ▲ | $3.25 ▲ | $1.59B ▲ |
| Q3-2025 | $1.54B ▼ | $327.4M ▼ | $908M ▼ | 59.05% ▼ | $2.49 ▼ | $1.3B ▼ |
| Q2-2025 | $1.69B ▲ | $341.1M ▲ | $1.01B ▲ | 59.82% ▲ | $2.81 ▲ | $1.46B ▲ |
| Q1-2025 | $1.64B ▲ | $327.6M ▼ | $956.2M ▲ | 58.22% ▲ | $2.63 ▲ | $1.37B ▲ |
| Q4-2024 | $1.53B | $357.4M | $874.6M | 57.34% | $2.4 | $1.22B |
What's going well?
Profits and earnings per share jumped sharply, helped by higher revenue and a big boost from other income. Gross margins remain very high, showing the business is efficient and profitable.
What's concerning?
Operating expenses are growing faster than revenue, which could pressure profits if it continues. A large portion of earnings comes from other income, not just the core business.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $4.55B ▲ | $198.42B ▲ | $169.7B ▲ | $28.73B ▲ |
| Q3-2025 | $2.57B ▲ | $187.14B ▲ | $158.95B ▲ | $28.19B ▲ |
| Q2-2025 | $2.1B ▲ | $179.91B ▲ | $152.17B ▲ | $27.74B ▲ |
| Q1-2025 | $1.52B ▼ | $157.83B ▲ | $130.8B ▲ | $27.03B ▲ |
| Q4-2024 | $3.01B | $137.45B | $110.96B | $26.49B |
What's financially strong about this company?
CME has more cash than debt, and its total debt is very low compared to its size. Shareholder equity is healthy and growing, and most assets are tangible or liquid.
What are the financial risks or weaknesses?
Current liabilities are extremely high, and current assets are reported as zero, which could signal a liquidity crunch if not a reporting issue. There is also a large chunk of goodwill and intangibles that could be written down.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $1.18B ▲ | $3.16B ▲ | $1.51B ▲ | $-19.21B ▼ | $0 ▼ | $3.16B ▲ |
| Q3-2025 | $908M ▼ | $968.1M ▼ | $-19.1M ▼ | $6.4B ▼ | $465.5M ▼ | $949.7M ▼ |
| Q2-2025 | $1.03B ▲ | $1.06B ▼ | $-18M ▼ | $21B ▲ | $576.2M ▼ | $1.04B ▼ |
| Q1-2025 | $956.2M ▲ | $1.12B ▲ | $-16M ▲ | $19.21B ▲ | $20.31B ▲ | $1.1B ▲ |
| Q4-2024 | $874.6M | $1.02B | $-25.3M | $-984.1M | $8.5M | $991.7M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
clearing and transaction fees | $1.34Bn ▲ | $1.39Bn ▲ | $1.23Bn ▼ | $1.33Bn ▲ |
MarketData | $190.00M ▲ | $200.00M ▲ | $200.00M ▲ | $210.00M ▲ |
OtherRevenue | $110.00M ▲ | $110.00M ▲ | $110.00M ▲ | $110.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at CME Group Inc.'s financial evolution and strategic trajectory over the past five years.
CME combines a rare set of strengths: steadily growing revenue, exceptionally high and improving profit margins, strong and rising free cash flow, and a conservative balance sheet with low net leverage and growing cash. Its market position is entrenched through powerful network effects, trusted central clearing, and a broad suite of benchmark products across multiple asset classes. Technological capabilities—anchored by Globex, the Google Cloud migration, and data and analytics offerings—further enhance its role as critical financial infrastructure. This financial and competitive profile provides significant resilience and strategic flexibility.
Key risks cluster around market structure, regulation, and execution. Trading and clearing volumes are sensitive to volatility, interest‑rate cycles, and macro conditions, which can slow growth in quieter periods. Regulatory changes could reshape economics in key products or invite more competition. The large and complex technology initiatives underway, particularly the cloud migration and new clearing services, carry operational and execution risk. Balance sheet anomalies in the latest year, including the disappearance of reported current items and retained earnings, point to changes that need to be understood in detail. Finally, the lack of explicit R&D disclosure makes it harder to assess long‑term investment levels in technology relative to emerging competitors, especially in areas like crypto and advanced data services.
CME’s recent trends point to a generally favorable outlook: a scalable, high‑margin business model; rising cash generation; and a strong competitive position anchored in essential market infrastructure. If the company continues to execute on its technology roadmap, expand its product set into emerging areas, and maintain disciplined capital management, it is well positioned to sustain attractive financial characteristics over time. The main uncertainties are external—regulatory shifts, market‑cycle impacts on trading activity, and competitive dynamics—and internal around the flawless execution of complex innovation projects. Overall, the business appears structurally strong, with its future trajectory largely dependent on how effectively it navigates these evolving risks and opportunities.
About CME Group Inc.
https://www.cmegroup.comCME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $1.65B ▲ | $388M ▲ | $1.17B ▲ | 70.84% ▲ | $3.25 ▲ | $1.59B ▲ |
| Q3-2025 | $1.54B ▼ | $327.4M ▼ | $908M ▼ | 59.05% ▼ | $2.49 ▼ | $1.3B ▼ |
| Q2-2025 | $1.69B ▲ | $341.1M ▲ | $1.01B ▲ | 59.82% ▲ | $2.81 ▲ | $1.46B ▲ |
| Q1-2025 | $1.64B ▲ | $327.6M ▼ | $956.2M ▲ | 58.22% ▲ | $2.63 ▲ | $1.37B ▲ |
| Q4-2024 | $1.53B | $357.4M | $874.6M | 57.34% | $2.4 | $1.22B |
What's going well?
Profits and earnings per share jumped sharply, helped by higher revenue and a big boost from other income. Gross margins remain very high, showing the business is efficient and profitable.
What's concerning?
Operating expenses are growing faster than revenue, which could pressure profits if it continues. A large portion of earnings comes from other income, not just the core business.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $4.55B ▲ | $198.42B ▲ | $169.7B ▲ | $28.73B ▲ |
| Q3-2025 | $2.57B ▲ | $187.14B ▲ | $158.95B ▲ | $28.19B ▲ |
| Q2-2025 | $2.1B ▲ | $179.91B ▲ | $152.17B ▲ | $27.74B ▲ |
| Q1-2025 | $1.52B ▼ | $157.83B ▲ | $130.8B ▲ | $27.03B ▲ |
| Q4-2024 | $3.01B | $137.45B | $110.96B | $26.49B |
What's financially strong about this company?
CME has more cash than debt, and its total debt is very low compared to its size. Shareholder equity is healthy and growing, and most assets are tangible or liquid.
What are the financial risks or weaknesses?
Current liabilities are extremely high, and current assets are reported as zero, which could signal a liquidity crunch if not a reporting issue. There is also a large chunk of goodwill and intangibles that could be written down.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $1.18B ▲ | $3.16B ▲ | $1.51B ▲ | $-19.21B ▼ | $0 ▼ | $3.16B ▲ |
| Q3-2025 | $908M ▼ | $968.1M ▼ | $-19.1M ▼ | $6.4B ▼ | $465.5M ▼ | $949.7M ▼ |
| Q2-2025 | $1.03B ▲ | $1.06B ▼ | $-18M ▼ | $21B ▲ | $576.2M ▼ | $1.04B ▼ |
| Q1-2025 | $956.2M ▲ | $1.12B ▲ | $-16M ▲ | $19.21B ▲ | $20.31B ▲ | $1.1B ▲ |
| Q4-2024 | $874.6M | $1.02B | $-25.3M | $-984.1M | $8.5M | $991.7M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
clearing and transaction fees | $1.34Bn ▲ | $1.39Bn ▲ | $1.23Bn ▼ | $1.33Bn ▲ |
MarketData | $190.00M ▲ | $200.00M ▲ | $200.00M ▲ | $210.00M ▲ |
OtherRevenue | $110.00M ▲ | $110.00M ▲ | $110.00M ▲ | $110.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at CME Group Inc.'s financial evolution and strategic trajectory over the past five years.
CME combines a rare set of strengths: steadily growing revenue, exceptionally high and improving profit margins, strong and rising free cash flow, and a conservative balance sheet with low net leverage and growing cash. Its market position is entrenched through powerful network effects, trusted central clearing, and a broad suite of benchmark products across multiple asset classes. Technological capabilities—anchored by Globex, the Google Cloud migration, and data and analytics offerings—further enhance its role as critical financial infrastructure. This financial and competitive profile provides significant resilience and strategic flexibility.
Key risks cluster around market structure, regulation, and execution. Trading and clearing volumes are sensitive to volatility, interest‑rate cycles, and macro conditions, which can slow growth in quieter periods. Regulatory changes could reshape economics in key products or invite more competition. The large and complex technology initiatives underway, particularly the cloud migration and new clearing services, carry operational and execution risk. Balance sheet anomalies in the latest year, including the disappearance of reported current items and retained earnings, point to changes that need to be understood in detail. Finally, the lack of explicit R&D disclosure makes it harder to assess long‑term investment levels in technology relative to emerging competitors, especially in areas like crypto and advanced data services.
CME’s recent trends point to a generally favorable outlook: a scalable, high‑margin business model; rising cash generation; and a strong competitive position anchored in essential market infrastructure. If the company continues to execute on its technology roadmap, expand its product set into emerging areas, and maintain disciplined capital management, it is well positioned to sustain attractive financial characteristics over time. The main uncertainties are external—regulatory shifts, market‑cycle impacts on trading activity, and competitive dynamics—and internal around the flawless execution of complex innovation projects. Overall, the business appears structurally strong, with its future trajectory largely dependent on how effectively it navigates these evolving risks and opportunities.

CEO
Terrence A. Duffy
Compensation Summary
(Year 2024)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2012-07-23 | Forward | 5:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 823
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
TD Cowen
Buy
Morgan Stanley
Overweight
Barclays
Equal Weight
RBC Capital
Sector Perform
JP Morgan
Underweight
Piper Sandler
Overweight
Grade Summary
Showing Top 6 of 13
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:35.9M
Value:$11.47B
BLACKROCK, INC.
Shares:31.26M
Value:$9.99B
BLACKROCK INC.
Shares:25.66M
Value:$8.2B
Summary
Showing Top 3 of 2,217

